중동 및 아프리카 제약 시장의 사이클로덱스트린 – 2030년까지의 산업 동향 및 예측

중동 및 아프리카 제약 시장 분석 및 규모의 사이클로덱스트린

최근, 제약 시장에서 사이클로덱스트린은 2023-2030년 예측 기간 동안 광범위하게 성장할 것으로 예상됩니다. 사이클로덱스트린은 얼굴 마스크, 크림, 로션과 같은 화장품 및 개인 관리 품목을 제조하는 데 광범위하게 사용되며, 향후 몇 년 동안 시장 확장을 증가시킬 것으로 예상됩니다. 한편, 전 세계적으로 면역력을 강화하는 식이 보충제의 인기가 증가함에 따라 예측 기간 동안 시장 확장이 증가할 가능성이 높습니다.

Data Bridge Market Research는 2023-2030년 예측 기간 동안 제약 시장에서 사이클로덱스트린의 성장률을 분석합니다. 언급된 예측 기간 동안 제약 시장에서 사이클로덱스트린의 예상 CAGR은 약 2.2%인 경향이 있습니다. 시장은 2022년에 0.98백만 달러로 평가되었으며 2030년까지 1.17백만 달러로 성장할 것입니다. Data Bridge Market Research 팀이 큐레이팅한 시장 보고서에는 시장 가치, 성장률, 시장 세그먼트, 지리적 범위, 시장 참여자 및 시장 시나리오와 같은 시장 통찰력 외에도 심층적인 전문가 분석, 환자 역학, 파이프라인 분석, 가격 분석 및 규제 프레임워크가 포함되어 있습니다.

중동 및 아프리카 제약 시장 범위 및 세분화의 사이클로덱스트린

Market Definition

Cyclodextrins are the kind of complex cyclic sugar which is made up of a macrocyclic ring of glucose subunits that is linked together by alpha-1,4 glycosidic linkages. Cyclodextrin is formed when a starch is decomposed enzymatically into simple molecules. Cyclodextrin is widely used in the pharmaceutical and chemical industries in the form of solvent component in medication delivery. Cyclodextrin is widely used to increase drug water solubility, stability, and bioavailability by encapsulating hydrophobic medicinal molecules in biological systems.   

Middle East And Africa Cyclodextrins in Pharma Market Dynamics

Drivers

• Increasing Consumption of Dietary Supplements

The increasing consumption of dietary supplements is projected to increase the market's growth. Excipients such as cyclodextrin are used in pharmaceutical and nutraceutical formulations. Also because of COVID-19 pandemic, physicians have prescribed a wide variety of antiviral therapeutics to patients to help them fight the virus early on. The increasing use of these medications has increased the cyclodextrin consumption, boosting market growth throughout the forecast period 2023-2030.

• Increasing investment for healthcare infrastructure

Another factor that is boosting the growth of the cyclodextrins in pharma market is the increasing healthcare expenditure that helps in improving its infrastructure. Additionally, numeorus government organizations aim to develop the healthcare infrastructure by growing their funding to influence cyclodextrins dynamics in the pharma market. Moreover, rising initiatives by private and public organizations to increase awareness will increase the demand for cyclodextrins in the pharma market. Furthermore, the huge drift of consumer behavior towards health and the rising use of cyclodextrins in renal diseases will also increase the cyclodextrins in pharma market growth.

Opportunities

• Huge Application in Drug Solubility And Dissolution

Cyclodextrins have a wide application in drug solubility and dissolution which are anticipated to dominate the market because of the presence of cyclodextrins for many administrations, such as oral, gastrointestinal, top-of-the-line drugs to increase drug efficacy. Thus, this boosts the market growth.   

• Rising Adoption of Direct Tender Segment

The direct tender channel is majorly increasing the market growth since the drugs are used for the cyclodextrins in pharma that can be obtained through direct tender on reasonable price and the patients receive treatment for prolonged period of time. Therefore, this factor enhances the market growth.

Restraints/Challenges

• High Cost of Treatment

There are numerous treatment methods which requires surgery and high-end medications that demand huge cost. The lower economic groups cannot retrieve these treatment processes. Therefore, this factor impedes the market growth since the treatment options are not feasible for all the economic groups.

• Lack of Reimbursement Policies

There is a lack of reimbursement for cyclodextrins in pharma, which are expected to restrict the market growth. Both public and private payers do not compensate majority of the treatment services. The high cost of such services vary, and there cannot be standardization. Therefore, this factor hampers the market growth.

This cyclodextrins in pharma market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the cyclodextrins in pharma market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Middle East And Africa Cyclodextrins in Pharma Market Scope

The cyclodextrins in pharma market is segmented on the basis of type, structure, nature, form, application, therapeutic areas and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

• Β Cyclodextrin
• 2-Hydroxypropyl-Β-Cyclodextrin
• Α Cyclodextrin
• γ-Cyclodextrin
• Randomly Methylated Β-Cyclodextrin
• Sulfobutylether Β-Cyclodextrin
• 2-Hydroxypropyl-Γ-Cyclodextrin

Structure

• Cyclodextrin Conjugates
• Mucoadhesive Drug Carriers
• Cyclodextrin Associates
• Amphiphilic Cyclodextrins
• Others

Nature

• Hydrophilic
• Hydrophobic

Form

• Solid
• Liquid

Application

• Drug Solubility and Dissolution
• Drug Bioavailability
• Drug Safety
• Drug Stability
• Others

Therapeutics Area

• Pain Management
• Cardiovascular Diseases
• Behavioral Disorder
• Cancer Therapy
• Rheumatoid Arthritis
• Epilepsy
• Niemann Pick Disease Type C (NPC)
• Others

Distribution Channel

• Direct Tender
• Retail Sales
• Others

Cyclodextrins In Pharma Market Regional Analysis/Insights

The cyclodextrins in pharma market is analyzed and market size insights and trends are provided by type, structure, nature, form, application, therapeutic areas and distribution channel as referenced above.

The major countries covered in the cyclodextrins in pharma market report are Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA).

South Africa is leading the Middle East and Africa cyclodextrins in pharma market due to increasing demand for pharmaceutical industry and rising awareness of the benefits of cyclodextrins.  

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of middle east and africa brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data. 

Competitive Landscape and Middle East And Africa Cyclodextrins in Pharma Market Share Analysis

The cyclodextrins in pharma market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, middle east and africa presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to cyclodextrins in pharma market

Key players operating in the cyclodextrins in pharma market include:

• Cambrex Corporation (U.S.)
• Cayman Chemical (U.S.)
• Wellona Pharma (India)
• Wacker Chemie AG (Germany)
• 토코팜 주식회사(중국)
• 로케트 프레르(프랑스)
• Midas Pharma GmbH(독일)
• 리간드 파마슈티컬스 인코퍼레이티드(미국)
• Cyclo Therapeutics, Inc. (미국)
• 지보첸후이생물기술유한공사(중국)
• 시안 델리 바이오케미컬 인더스트리 주식회사(중국)
• 머크 KGaA(독일)
• Otto Chemie Pvt. Ltd. (인도)
• VIO CHEMICALS(스위스)
• 애슐랜드(미국)
• TCI Chemicals (인도) Pvt. Ltd. (일본)

SKU-55856